a 501(c)(3) educational nonprofit organization

KEYSTONE SYMPOSIA ON MOLECULAR & CELLULAR BIOLOGY

2012Annual Repor t

The 2012 Meeting SeasonNovember 2011 – June 2012

Malnutrition, Gut-Microbial Interactions and Mucosal Immunity to VaccinesNovember 7–11, 2011 • Le Meridien New Delhi • New Delhi • India

Chemokines and Leukocyte Trafficking in Homeostasis and InflammationJanuary 8–13, 2012 • Beaver Run Resort • Breckenridge, Colorado • USA

Nucleic Acid Therapeutics: From Base Pairs to BedsidesJanuary 10–15, 2012 • Eldorado Hotel & Spa • Santa Fe, New Mexico • USA

Drug Discovery for Protozoan Parasitesjoint with Fungal Pathogens: From Basic Biology to Drug DiscoveryJanuary 15–20, 2012 • Santa Fe Community Convention Center • Santa Fe, New Mexico • USA

Angiogenesis: Advances in Basic Science and Therapeutic ApplicationsJanuary 16–21, 2012 • Snowbird Resort • Snowbird, Utah • USA

Epigenomics joint with Chromatin DynamicsJanuary 17–22, 2012 • Keystone Resort • Keystone, Colorado • USA

Rheumatoid Arthritis: Molecular and Clinical InsightsJanuary 19–24, 2012 • Eldorado Hotel & Spa • Santa Fe, New Mexico • USA

Membranes in Motion: From Molecules to DiseaseJanuary 22–27, 2012 • Granlibakken Resort • Tahoe City, California • USA

Cardiovascular Development and RegenerationJanuary 22–27, 2012 • Sagebrush Inn and Conference Center • Taos, New Mexico • USA

High-Throughput Structural Biologyjoint with Integrative Structural Biology: From Atoms to CellsJanuary 22–27, 2012 • Keystone Resort • Keystone, Colorado • USA

Genetic and Molecular Basis of Obesity and Body Weight Regulationjoint with Emerging Molecular Mechanisms for the Pathogenesis of DiabetesJanuary 29–February 3, 2012 • Santa Fe Community Convention Center • Santa Fe, New Mexico • USA

The Biology of Cytokinesjoint with Th17 Cells in Health and DiseaseFebruary 5–10, 2012 • Keystone Resort • Keystone, Colorado • USA

Gene Silencing by Small RNAsFebruary 7–12, 2012 • Fairmont Hotel Vancouver • Vancouver, British Columbia • Canada

Sirtuins in Metabolism, Aging and DiseaseFebruary 12–16, 2012 • Granlibakken Resort • Tahoe City, California • USA

Chemical Biology and Novel Tools in PharmacologyFebruary 12–16, 2012 • Hilton Santa Fe/Historic Plaza • Santa Fe, New Mexico • USA

Cancer and Metabolismjoint with Advances in Hypoxic Signaling: From Bench to BedsideFebruary 12–17, 2012 • Fairmont Banff Springs • Banff, Alberta • Canada

G Protein-Coupled Receptors: Molecular Mechanisms and Novel Functional InsightsFebruary 17–22, 2012 • Fairmont Banff Springs • Banff, Alberta • Canada

Complex Traits: Genomics and Computational ApproachesFebruary 20–25, 2012 • Beaver Run Resort • Breckenridge, Colorado • USA

ApoE, Alzheimer’s and Lipoprotein Biologyjoint with Clinical and Molecular Biology of Acute and Chronic Traumatic EncephalopathiesFebruary 26–March 2, 2012 • Keystone Resort • Keystone, Colorado • USA

Protein-RNA Interactions in Biology and DiseaseMarch 4–9, 2012 • Hilton Santa Fe/Historic Plaza • Santa Fe, New Mexico • USA

Innate Immunity: Sensing the Microbes and Damage Signalsjoint with The MicrobiomeMarch 4–9, 2012 • Keystone Resort • Keystone, Colorado • USA

Nuclear Events in Plant Gene Expression and SignalingMarch 6–11, 2012 • Sagebrush Inn and Conference Center • Taos, New Mexico • USA

The Life of a Stem Cell: From Birth to DeathMarch 11–16, 2012 • Resort at Squaw Creek • Olympic Valley, California • USA

Regulation of Lymphocyte SignalingMarch 11–16, 2012 • Keystone Resort • Keystone, Colorado • USA

Complications of Diabetes: Mechanisms of Injury and Failure of RepairMarch 11–16, 2012 • Boston Park Plaza & Towers • Boston, Massachusetts • USA

Mutations, Malignancy and Memory – Antibodies and ImmunityMarch 18–22, 2012 • Boston Park Plaza & Towers • Boston, Massachusetts • USA

NF-kB Signaling and Biology: From Bench to Bedsidejoint with Ubiquitin SignalingMarch 18–23, 2012 • Whistler Conference Centre • Whistler, British Columbia • Canada

Drug Design: Meeting the Challenges of Drug DiscoveryMarch 19–23, 2012 • Granlibakken Resort • Tahoe City, California • USA

Mitochondrial Dynamics and Functionjoint with Cell Death Pathways: Beyond Apoptosis March 19–24, 2012 • Fairmont Banff Springs • Banff, Alberta • Canada

HIV Vaccines joint with Viral Immunity and Host Gene Influence March 21–26, 2012 • Keystone Resort • Keystone, Colorado • USA

Molecular Basis of Vascular Inflammation and AtherosclerosisMarch 25–30, 2012 • Big Sky Resort • Big Sky, Montana • USA

Advances in Islet BiologyMarch 25–30, 2012 • Portola Hotel & Spa • Monterey, California • USA

Cell Biology of Virus Entry, Replication and Pathogenesisjoint with Frontiers in HIV Pathogenesis, Therapy and EradicationMarch 26–31, 2012 • Whistler Conference Centre • Whistler, British Columbia • Canada

Fibrosis: Translation of Basic Research to Human Disease and Novel TherapeuticsMarch 30–April 4, 2012 • Big Sky Resort • Big Sky, Montana • USA

Non-Coding RNAs joint with Eukaryotic TranscriptionMarch 31–April 5, 2012 • Snowbird Resort • Snowbird, Utah • USA

Synapses and Circuits: From Formation to DiseaseApril 1–6, 2012 • Sheraton Steamboat Resort • Steamboat Springs, Colorado • USA

Regenerative Tissue Engineering and Transplantationjoint with Mechanisms of Whole Organ Regeneration April 1–6, 2012 • Beaver Run Resort • Breckenridge, Colorado • USA

Nuclear Receptor Matrix: ReloadedApril 15–20, 2012 • Fairmont Chateau Whistler • Whistler, British Columbia • Canada

Proteomics, InteractomesMay 7–12, 2012 • Clarion Hotel Sign • Stockholm • Sweden

Drug Resistance and Persistence in TuberculosisMay 13–18, 2012 • Speke Resort & Conference Centre • Kampala • Uganda

The Role of Inflammation during CarcinogenesisMay 20–25, 2012 • Royal Dublin Society • Dublin • Ireland

In 2012, Keystone Symposia celebrated the 40th anniversary of its very first meeting, which took place March 12-17, 1972 in Squaw Valley, California on membrane biology. At that time, the organization was simply known as the UCLA Symposium, and only one meeting per year

was envisioned. It wasn’t until 1980 that the organization expanded to holding three meetings per year, and growth has continued every year since. Keystone Symposia is now a completely independent nonprofit organization and holds 50-60 conferences annually throughout the world across a broad array of the life sciences, focusing on biomedical research areas that hold real promise for positive impact on the most pressing health issues of our time.

The organization’s growth would not be possible without the loyal and ongoing support ofthe corporations, foundations, government institutes and individuals listed later in this Annual Report. Via funding of scholar-ships and travel awards, their support also enables young investigators and those from developing countries to attend confer-ences that would be otherwise beyond reach. The entire Board of Directors joins the staff in thanking these dedicated support-ers and commending them for the commitment they have demonstrated to our mission.

What will the next 40 years bring? We have every faith that in spite of the rapidly changing nature of science communication and collaboration, the value of face-to-face conferences will never wane. At the same time, the organization is actively exploring how new virtual technologies might supplement the conferences and broaden their reach so that even more participants might benefit. The organization is very well positioned to have an ever-growing impact on life science discovery.

Sincerely,

Juleen R. ZierathChair, Board of Directors, Keystone Symposia and Professor, Karolinska Institutet

This letter gives me the opportunity to praise all the people who contribute to the quality of Keystone Symposia meetings. Credit belongs to the Scientific Advisory Board (SAB), which recommends topics and scientific organizers; the Scientific Organizers, who design the

programs and select speakers, and each of the Keystone Symposia staff, who help implement the conferences and make them hospitable. In addition, each year, even before the SAB gets the process started, many scientists contribute ideas about potential meeting topics online and via responses to post-meeting surveys.

In 2012, we received a new grant from the Bill & Melinda Gates Foundation that will support travel awards for scientists coming to our meetings from developing countries for fiscal years 2013, 2014 and 2015. Overall support for the conferences from corporate, government, private foundation and individual contributors was the best ever, which comprised about 38% of our operating budget. Exit surveys indicate that attendees rated highly the opportunities for professional development at our conferences, and also gave high ratings for impact on their research, regardless of career stage, affiliation or meeting role.

Each year we try some new things: novel topics or pairings of joint meetings, global venues, city venues, programming of ancillary workshops on related themes, activities to enhance the participation and value for early-career scientists. For example, in 2012 we held our first meetings in India (New Delhi) and Sweden (Stockholm), and another meeting in Kampala, Uganda, a popular venue that we have used before. We held our first meeting on Traumatic Brain Injury, a topic that is receiving increasing awareness of its importance in medicine especially as it relates to sports and battlefield injuries. The feedback we receive from attendees on these experiments is extremely helpful for our planning of future symposia. Thank you to all who contribute to Keystone Symposia. We would not be able to accomplish our mission without your support.

James W. Aiken, Ph.D.President and Chief Executive Officer, Keystone Symposia 3

From the Chair of the Board

From the Chief Executive Officer

3

2012 EXPENSE BREAKDOWN

The charts below are intended to provide a snapshot of Keystone Symposia’s 2012 finances and activities. Please visit keystonesymposia.org/AboutUs/AnnualReport.cfm to view the full audited statement of financial condition and statement of activities for the fiscal year July 1, 2011 – June 30, 2012.

2012 REVENUE BREAKDOWN

Investment Income/Miscellaneous Income (6.48%)

Corporate & Foundation Gifts (31.98%)

Government Grants (5.64%)

Individual Gifts (.30%)

Registration Fees/Earned Income(55.60%)

4

A full 83.55% of Keystone Symposia’s expenditures go toward educational programs including meeting programs, scholarships, travel awards and diversity initiatives.

Breakdown of the Year

Educational Programs (74.25%)

Scholarships, Travel Awards& Diversity Initiatives (9.30%)

Fundraising & Development (3.67%)

Management & General (12.78%)

2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

13,956

7,340

13,509

6,587

13,015

5,962

11,512

5,736

11,222

5,400

10,329

5,060

Attendees & Speakers

Abstract Submissions*

2003 2004 2005 2006 2007 2008 2009 2010 2011* 2012*

929903

711681

619

546

459

Scholarships

Underrepresented Trainee Scholarships

Global Health Travel Awards

TOTAL MEETING ATTENDANCE & ABSTRACT SUBMISSIONS*

SCHOLARSHIPS & TRAVEL AWARDS

12,303

6,547

930

5

AVERAGE ATTENDANCE & ABSTRACTS* PER MEETING

2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

Average Attendance

Average Number of Abstracts*

5856505444464152

6,857

13,554

252 244262

241

270

242 241 237

123 117130

110132 122 127 126

Number of Meetings

*abstract count does not include speaker abstracts

*abstract count does not include speaker abstracts

13,770

7,381

55

250

134

882*

*Scholarship amount was increased from $1,000 to $1,200 in 2011, which slightly reduced the total number awarded.

12,360

6,603

55

225

120

835*

MEETING “EXCELLENT” RATINGS AS A PERCENT OF ALL RATINGS (BASED ON ATTENDEE SURVEYS)

VALUE PARTICIPANTS GAINED FROM THE 2012 MEETINGS (BASED ON ATTENDEE SURVEYS)

Poster/Abstract Quality

Quality of Plenary Speakers

Overall Scientific Content QualityScientific Value Compared to Other Meetings

60%

55%

50%

45%

40%

35%

30%

25%

20% 2007 2008 2009 2010 2011 2012

Made a Useful Contact Saved Research Time/Money or Meeting Facilitated Accelerated Research Objectives Junior-Senior Interactions (N=4,035) (N=4,035) (N=4,035) 6

45%

34%

15%

3%1%

21%

29%

43%

3%1%

Strongly Agree

Somewhat Agree

Neutral

Somewhat Disagree

Strongly Disagree

PARTICIPATION OF THE NEXT GENERATION OF INVESTIGATORS (PERCENT OF TOTAL & ABSOLUTE NUMBERS)

2008 2009 2010 2011 2012

64(4%)

109(7%)

92(7%)

130(9%)

Assistant Professor & Young Investigator Speakers & Organizers

Total Assistant Professor & Young Investigator Attendees

Total Student & Postdoctoral Fellow Attendees

1,143(8%)

1,104(9%)

1,403(10%)

5,415(39%)

4,930(40%)

5,564(41%)

941(7%)

5,368(40%)

160(11%)

1,222(10%)

4,679(38%)

10%

28%

56%

4%1%

Keystone Symposia is fortunate to receive substantial ongoing support from the pharmaceutical and biotechnology industries, charitable foundations and individuals. We are also honored to be the recipient of numerous grants from the US National Institutes of Health and other government agencies around the world. These gifts and grants are used to provide

scholarships for graduate students and postdoctoral fellows, travel awards for scientists from developing nations and subsidies for the travel and lodging costs of scientific speakers from academic and other nonprofit laboratories and institutions.

For the 2012 meeting season and fiscal year, we received a total of $4.34 million from government, corporate, foundation and individual sources, as shown in the chart below. This funding is crucial in supporting Keystone Symposia’s mission to serve as a catalyst for the advancement of biomedical and life sciences and to accelerate applications that benefit humankind.

Keystone Symposia gratefully acknowledges donors who gave in the 2012 fiscal year. Their generous support makes possible the outstanding scientific quality of our meetings and unsurpassed opportunities for interaction and collaboration among participants. To make a gift, please contact the Development office by telephone at 970.262.1474 or by e-mail at chrisatwood@keystonesymposia.org. “Future of Science Fund” individual donations can also be made over the Internet at www.keystonesymposia.org/ScienceFund. And please visit our new website, www.ksgift.org, for more information on planned giving opportunities and becoming a member of The Keystone Society. This site also provides the opportunity to honor a mentor or loved one via named funds.

Christopher Atwood, D.Min.Director of Development, Keystone Symposia

7

Strongly Agree

Somewhat Agree

Neutral

Somewhat Disagree

Strongly Disagree

Assistant Professor & Young Investigator Speakers & Organizers

Total Assistant Professor & Young Investigator Attendees

Total Student & Postdoctoral Fellow Attendees

Donor Support

Corporate Gifts: $1,273,572 (29%)

Foundation Gifts: $1,131,883(26%)

US Federal Government Grants: $891,035(21%)

Other Government Grants: $53,368 (1%)

In-Kind Gifts:$936,824(22%)

Individual Gifts: $54,253 (1%)

CHAMPIONSTop-tier donors making an ongoing, annual commitment of $100,000+. Their public championing of Keystone Symposia’s cause provides inspirational leadership commitment to our shared scientific mission of catalyzing collaborations, accelerating discoveries, and preparing and positioning the next generation of leading life scientists.

Bill & Melinda Gates FoundationMerck & Co., Inc.Novartis Institutes for BioMedical ResearchScience for Life Laboratory – StockholmKnut and Alice Wallenberg Foundation

SUSTAINING BENEFACTORSDonors making a three-year commitment of at least $50,000 per year. Their generous support is crucial to sustain Keystone Symposia’s ability to plan future scientific conferences focused on emerging topics and excellence in science.

Bayer USA FoundationTakeda Pharmaceutical Company Limited

BENEFACTORSDonors of $50,000 or above. We are very grateful for their extraordinary commitment to our mission to connect the scientific community and accelerate discoveries that benefit society. Special thanks to those organizations that provide consistent, annual Benefactor-level support.

American College of Rheumatology Research and Education FoundationEducational donation provided by AmgenGenentech, Inc.Novo Nordisk A/S

SUSTAINING SPONSORSDonors making a three-year commitment of $25,000 to $49,999 per year. Their generous support is crucial to Keystone Symposia’s ability to plan future scientific conferences focused on emerging topics and excellence in science.

Abbott LaboratoriesAstellas Pharma Inc.Biogen IdecBoehringer Ingelheim Pharmaceuticals, Inc.Celgene CorporationGilead Sciences, Inc.Hoffmann-La Roche, Inc.

SPONSORSDonors contributing $25,000 to $49,999. These generous gifts allow us to convene meetings in a wide variety of important areas. Special thanks to those organizations that provide consistent, annual Sponsor-level support.

AstraZeneca Pharmaceuticals, L.P.Bristol-Myers Squibb CompanyGlaxoSmithKlineGlaxoSmithKline UKIsis Pharmaceuticals, Inc.

The listings on this page and the next five pages reflect donations for the fiscal year beginning July 1, 2011 and ending June 30, 2012.

8

Donor Support

Infinity PharmaceuticalsMedImmuneOnyx Pharmaceuticals, Inc.Regulus Therapeutics Inc.Sangamo BioSciences, Inc.Vertex Pharmaceuticals Incorporated

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Educational grant from Lilly USA, LLCMonsanto CompanySanofi US

Pfizer Inc.Science Foundation IrelandStanford University via a California Institute for Regenerative Medicine (CIRM) Conference Grant

The listings on this page and the next five pages reflect donations for the fiscal year beginning July 1, 2011 and ending June 30, 2012.

*Indicates a gift to the Directors’ Fund, which allows Keystone Symposia’s President/CEO and Directors to schedule and support meetings in the early stages of research.

9

PARTNERS, PATRONS, DONORS AND CONTRIBUTORS

Keystone Symposia wishes to thank the following donors to the 2012 meeting series. Their generous support makes possible the outstanding scientific quality of our meetings and unsurpassed opportunities for interaction among attending scientists.

PARTNERS($10,000–$24,999)

Boehringer Ingelheim StiftungCell Signaling Technology, Inc.Gordon and Betty Moore FoundationInterMune, Inc.*

PATRONS($5,000–$9,999)

Aastrom Biosciences, Inc.*Alnylam Pharmaceuticals, Inc.*Avanti Polar Lipids, Inc.BioVentures, Inc.*Coy Laboratory Products Inc.*The Ellison Medical FoundationFáilte IrelandGenentech, Inc.*ImQuest BioSciences*Integrated DNA Technologies*Janssen Research & Development LLC*

DIVERSITY PROGRAM SUPPORT

Keystone Symposia is grateful to the following 2012 supporters of its Diversity in Life Science Programs.

Biogen IdecNovartis Institutes for BioMedical Research

National Institute of General Medical Sciences (NIGMS), NIH, Minority Access to Research Careers (MARC)

DIRECTORS’ FUND CHAMPIONS & BENEFACTORSThe following donors with unrestricted gifts of $50,000 or more enabled Keystone Symposia’s President/CEO and Directors to schedule meetings in a variety of important areas, many of which are in the early stages of research.

Educational donation provided by AmgenBayer USA FoundationGenentech, Inc.Merck & Co., Inc.

DIRECTORS’ FUND SPONSORSThe following donors with unrestricted gifts from $25,000 to $49,999 also provided invaluable support to the Directors’ Fund.

Abbott LaboratoriesAstellas Pharma Inc.Biogen IdecBoehringer Ingelheim Pharmaceuticals, Inc.Bristol-Myers Squibb CompanyCelgene CorporationGilead Sciences, Inc.GlaxoSmithKlineGlaxoSmithKline UKHoffmann-La Roche, Inc.Infinity Pharmaceuticals

Mercodia, Inc.*Educational grant from Millennium Pharmaceuticals, Inc., Novus Biologicals, Inc.*Rigel Pharmaceuticals, Inc.*Ruskinn Technology Ltd, a division of the Baker Company, Inc.*Seahorse Bioscience, Inc.Sigma Life Science*The Company of Biologists LtdZymo Research Corporation*

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Educational grant from Lilly USA, LLCMonsanto CompanySanofi US

Novartis Institutes for BioMedical ResearchNovo Nordisk A/S Pfizer Inc.Takeda Pharmaceutical Company Limited

Isis Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Educational grant from Lilly USA, LLCMedImmuneMonsanto CompanyOnyx Pharmaceuticals, Inc.Regulus Therapeutics Inc.Sangamo BioSciences, Inc.Sanofi USVertex Pharmaceuticals Incorporated

JDRFLandes Bioscience*March of Dimes FoundationPfizer Oncology*

Hain Lifescience GmbHHypOxygen*InQ Biosciences Corporation*iPierian, Inc.*ISOTEC, a member of the Sigma-Aldrich Group*Labome*Molecular and Cellular ProteomicsMyriad-RBM*New England Biolabs, Inc.*Promedior, Inc.Promega CorporationR&D Systems, Inc.*Stromedix, Inc.*Syngenta Biotechnology, Inc.*Takeda California*Thermo Scientific

US GOVERNMENT GRANTS

Keystone Symposia appreciates grants to support various 2012 meetings received from the following government agencies:

National Institutes of Health (NIH):National Cancer Institute (NCI)National Human Genome Research Institute (NHGRI)National Heart, Lung, and Blood Institute (NHLBI)National Institute on Aging (NIA)National Institute of Allergy and Infectious Diseases (NIAID)Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)National Institute of Dental and Cranofacial Research (NIDCR)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)National Institute of Environmental Health Sciences (NIEHS)National Institute of General Medical Sciences (NIGMS)National Institute of Mental Health (NIMH)National Institute of Neurological Disorders and Stroke (NINDS)

National Science Foundation (NSF)

*Indicates a gift to the Directors’ Fund, which allows Keystone Symposia’s President/CEO and Directors to schedule and support meetings in the early stages of research.

10

PARTNERS, PATRONS, DONORS AND CONTRIBUTORS (CONTINUED)

DONORS($2,500–$4,999)

ActivX Biosciences*Addgene*AdipoGen International*Agilent Technologies*ALPCO Diagnostics*Alzheimer’s Drug Discovery FoundationBoston Biochem, an R&D Systems CompanyBruker AXS, Inc.*Bruker BioSpin Corp.*CEDARLANE*ChemoCentryx, Inc.*Chroma Technology Corporation*Cubist Pharmaceuticals, Inc.*Cytokine journalDevelopment, The Company of Biologists LtdeBioscience, Inc.*Epizyme, Inc.Found Animals’ Michelson Prize & Grants in Reproductive BiologyGenScript USA Inc.*

CONTRIBUTORS(up to $2,499)

ACS Chemical BiologyAmerican Heart Association’s Council on Basic Cardiovascular SciencesAmplyx Pharmaceuticals, Inc.Avila TherapeuticsCeleraDepartment of Molecular Genetics and Microbiology, Duke University Medical CenterGeneBlue Corporation*

Donor Support

Journal of Biological ChemistryJournal of Lipid ResearchOneWorld HealthProcter & Gamble CompanyRigaku Americas Corporation*ViaCyte, Inc.

In March 1972, Keytone Symposia (then known as ICN-UCLA Symposium) held its first conference – on “Membrane Proteins” in Squaw Valley, California. Among the attendees was Emeritus Board Member Ed Dennis, pictured facing the camera to left of center.

Also in attendance at the inaugural Keystone Symposia meeting in 1972 was Nobel Laureate Arthur Kornberg, at left in the brown beret.

The conference in Squaw Valley laid the groundwork for future meetings in western ski resorts where participants coudl relax in an invigorating, natural setting while discussing hard science.

11

These generous alumni of previous meetings and others with a passion for ensuring a future of scientific discovery that benefits humankind have made gifts in the fiscal year ending June 30, 2012 to support the Keystone Symposia Future of Science Fund. Through their generosity, we are able to provide scholarships and travel awards to the next generation of biomedical and life scientists, whose education and careers are enhanced by the opportunity to attend meetings and interact with the world’s leading senior scientists.

In addition to funding for general and underrepresented minority scholarships and travel awards for investigators originating from coun-tries most affected by topics of specific meetings, Future of Science Fund supporters can also contribute to help us meet general meeting program expenses, as well as program costs for specific meetings of their choice.

PRESIDENT’S CIRCLE ($10,000+)The Elkes Foundation

FOUNDERS’ SOCIETY ($5,000–$9,999)A.J. MillerDavid and Marcy Woodland

KEYSTONE CHAMPIONS ($1,000–$4,999)Jim and Sue AikenChristopher AtwoodKenneth W. BairMargaret Liu, Robert JohnsonAnthony PawsonAlessandro Pocai, Marco and Sofia Pocai with matching gift from Merck Partnership for GivingRoy G. Michell Charitable Foundation and TrustSidney E. Frank FoundationCraig B. ThompsonJo VineyJuleen Zierath

KEYSTONE BENEFACTORS ($500–$999)Raymond N. DuBoisJoseph HeitmanLaura L. Kiessling, Ronald T. RainesMichinori KoharaSuraj Manrao Student Travel FundTerry J. OpgenorthAndrew D. RobertsonKazuo TsubotaSally WenzelIan WilsonMasayuki Yamamoto

KEYSTONE PATRONS ($100–$499)Stephen Bartelmez, Elizabeth BartelmezCarole L. BassettJeff BergelsonRaymond BirgeAlberto BosqueVicki BoussiotisRalph A. BradshawSten Braesch-AndersenRichard BreyerAndrew ButlerDaniel H. ConwayMaria Valeria CorriasRobert W. CraigShoulian Dong

KEYSTONE PATRONS (continued)Robert H. EckelLee EllisBeverly EmersonJohn FoleySarah GaffenCurtis C. HarrisMichèle HimmelspachTakeshi IkeuchiMark H. KaplanChristopher KarpKyung Hyun KimYoung Ho KimGerald KoelschShohei KoideMasayasu KojimaTakeshi KuroseMahin D. MainesPhyllis McNeilShi-Yuan (Tina) Meng with matching gift from Amgen Foundation Matching Gift ProgramJonathan MooreKarim NadraVictor NussenzweigOpokua Ofori-AnyinamEric ParkerMarc PrentkiSteven ReinerOle Petter RekvigBeverly Rothermel, in memory of Daphne Land RothermelEdward B. SandersNaoyuki SatoAlan SherYan Shi with matching gift from Bristol-Myers Squibb Company Employee Giving ProgramRebecca ShillingGregory T. SpearSteven L. ReinerPeter StropGerald SufrinLorraine SymingtonYutaka TagayaJames W. ThomasTomoaki HorieJames B. TragerToshihiro UmeharaTerry UntermanJo Viney

KEYSTONE PATRONS (continued)Sih-han WangStephanie Wengert WattsMarsha Wills KarpAprilianto Eddy WiriaLawrence J WysockiLawrence WysockiShigeyuki YokoyamaReza ZarnegarZongde ZhangAnonymous (1)

KEYSTONE CONTRIBUTORS ($10–$99)Mridu AcharyaYasunori AizawaStephen AndersonPaulo AntasEmily C. BarkerAhmed Seif BausLinda Hildegard BergersenDalibor BlazekRamireddy BommireddySteffen A. BordenLaura Wells BowersRolf A. BrekkenViolet BumahByambajav BuyandelgerErin CarlsonKenneth E. CarlsonRomain CartoniDhyan ChandraZhiyong ChengElena ChertovaAurelie CleretFrank GJ CobelensDenise Cooper, in memory of Adam F. CooperAnne E. CorcoranCarolyn B. CoyneRoxanne CrevelingBruce CronsteinPradyot DashGeraint Rhys DaviesXavier J. de Mollerat du JeuGuillaume DissUgo D’OroIrina Dulubovalluis Espinosa

Keystone Symposia Future of Science Fund Donors

12

KEYSTONE CONTRIBUTORS (continued) Tekalign EtichaJanelle M. FassbenderMichael ForstnerNicole FrahmTomoaki FujiiStefania GallucciJoseph A. GarciaJennifer GrantJustin M. GreeneAlla GrishokJean-Charles J. B. GrivelJulien GuergnonShabirul HaquePaul HarrisTakamitsu HattoriThomas J. HawkeJoerg HeerenAndrew J. HendersonMorley D. HollenbergCarlos HuertaReiko InagiRahizan IssaYogesh S. JeelallMing JiangSusan JohnsonSarah E. JuncoYukio KatoThomas KietzmannYutaka KikuchiYukio KitadeMichael KlagsbrunRaymond L. KongerRobert A. KozaTomoko KozuHans E. KrokanIrwin Jack KurlandKatja A. LamiaTae Weon Lee, with matching gift from Amgen Inc.Hong LingMary LoekenSarah J. LuekingJincai LuoFrancis W. LuscinskasThomas Alexander LutzAkira MaedaAdriana R. MantegazzaBryan MarshallCindy M. MartinMelanie P. MatheuWilliam A. McLaughlinSilvia D. MelgarVanessa MichelouAusten J. MilnerwoodWladek MinorMasayuki MiyasakaClaudia MonacoSulakshana P. Mukherjee

Desire Molouh Mama NsangouSakol PanyimMaria V. PapadopoulouAlexander PertsemlidisCherylene PlewaStefan PöhlmannPatrick J. PollardAdelina PradoMaría Belén PradosChunfeng QuNarmela RabiradParameswaran RamakrishnanSamrina RehmanJoseph M. ReynoldsMargaret Elizabeth RossChristopher RuddLeonardo SahelijoSurinder S. SahotaUma SankarQuentin J. SattentauJohn SchellWilfried SchgoerRichard ScottAdriana Secatto SartiErin Leah SeifertAshu SharmaBarry ShurPJ Simpson-Haidaris, in memory of Kylie Taylor SimpsonSandra C. SouzaRadu V. StanShoukichi TakahamaJennifer TenorClifford Graham TepperErik ToonenJames TragerCagla TukelAna Alejandra Tula-SanchezEroboghene E. UboguYoshihiro UedaThomas VallimAlejandro Vasquez RifoPaula VertinoSandhya VisweswariahMarc VooijsYegor VoroninDomagoj VucicSabine WenzelJohn H. WhiteDoris WilflingsederWilton WilliamsNicholas A. WilliamsonKaren WuGiles See How YeoLijuan YuanAndreas ZirlikAnonymous (1)

Keystone Symposia Future of Science Fund Donors

Unseasonably warm weather in the Rockies made this a popular sight at 2012 conferences, including the joint meetings on “Innate Immunity” and “The Microbiome” at Keystone Resort, Colorado in March 2012.

Dr. Richard A. Young of Whitehead Institute of Biomedical Research delivered the joint keynote address at the meetings on “Epigenomics” and “Chromatin Dynamics” at Keystone Resort in January 2012.

In May 2012, we held our second meeting in Kampala, Uganda – on “Drug Resistance and Persistence in Tuberculosis.”

In conjunction with the first meeting on Traumatic Brain Injury, Keystone Symposia hosted a free community forum attended by approximately 150 people at the Pavilion in Silverthorne, Colorado.

13

BENEFACTORS ($50,000+)

BioMed Central LtdCell PressNature Publishing GroupThe ScientistWiley-Blackwell

SPONSORS ($25,000–$49,999)

American Association for the Advancement of ScienceCold Spring Harbor Laboratory PressLandes BioscienceThe Rockefeller University Press – The Journal of Cell Biology

PARTNERS ($10,000–$24,999)

ACS Chemical BiologyACS PublicationsEMBO (European Molecular Biology Organization)FOCIS (Federation of Clinical Immunology Societies)Mary Ann Liebert, Inc. publishersPLOSProceedings of the National Academy of Sciences (PNAS)Pubget Inc.The Rockefeller University Press – The Journal of Experimental Medicine

PATRONS ($5,000–$9,999)

Royal Society of ChemistryS. Karger A.G.The Company of Biologists LtdThe Journal of Rheumatology

CONTRIBUTORS (up to $2,499)

Beatson Institute for Cancer ResearchCo-Action PublishingEMBL (European Molecular Biology Laboratory)SAGE PublicationsThe Journal of Clinical Investigation

The following publishers, societies and other organizations provided in-kind marketing and advertising support that helped publicize the 2012 Keystone Symposia meeting series.

The following companies generously agreed to forego reimbursements for speaker travel and lodging expenses in order to support 2012 Keystone Symposia meeting programs.

Amgen Inc.Anacor Pharmaceuticals, Inc.Aragon Pharmaceuticals, Inc.AstraZenecaAthersys Inc.Avid Radiopharmaceuticals, Inc.Avila TherapeuticsBristol-Myers Squibb CompanyCarmot Therapeutics, Inc.CrucellDynavax Technologies CorporationEli Lilly and CompanyEMBO Young Investigator ProgrammeEpizyme, Inc.Genentech, Inc.Genomics Institute of the Novartis Research FoundationGenzyme CorporationGlaxoSmithKlineGlaxoSmithKline / DDDWGlaxoSmithKline R&D ChinaHeptares Therapeutics LtdHoffmann-La Roche, Inc.Isis Pharmaceuticals, Inc.

MedImmuneMerck & Co., Inc.Merck Research LaboratoriesMetabolic Solutions Development Company, LLC.Millennium Pharmaceuticals, Inc., The Takeda Oncology CompanyNovartis Institute for Tropical DiseasesNovartis Institutes for BioMedical ResearchNovartis Pharma AGOptibrium Ltd.Osiris Therapeutics, Inc.Pacific BiosciencesProsensa TherapeuticsRegeneron Pharmaceuticals, Inc.Regulus Therapeutics Inc.RXi PharmaceuticalsScynexis, Inc.Sirtris, a GSK CompanyStromedix, Inc.TekmiraTibotec BVBAViaCyte, Inc.

MARKETING/ADVERTISING IN-KIND DONORS

SPEAKER GIFT-IN-KIND DONORS

Keystone Symposia In-Kind Donors

Juleen R. Zierath, Ph.D.Chair of the Board, Keystone SymposiaProfessor, Molecular Medicine and Surgery, Karolinska Institutet

Craig B. Thompson, M.D. Secretary of the BoardChair, Scientific Advisory Board, Keystone SymposiaPresident and CEO, Memorial Sloan-Kettering Cancer Center

Terry J. Opgenorth, Ph.D.Treasurer of the BoardChair, Finance Committee, Keystone SymposiaChief Operating Officer, NeoTREXCSU Ventures, Inc., Colorado State University

James W. Aiken, Ph.D.President and Chief Executive OfficerKeystone Symposia on Molecular and Cellular Biology

Kenneth W. Bair, Ph.D.Chair, Audit Committee, Keystone SymposiaSenior Vice President and Head, Research and Development Forma Therapeutics, Inc.

Beverly M. Emerson, Ph.D.Chair, Personnel Committee, Keystone SymposiaProfessor, Regulatory Biology LaboratoryThe Salk Institute

Peter M. Finan, Ph.D.Director, Pathways BiologyDevelopmental and Molecular PathwaysNovartis Institutes for BioMedical Research

Heidi E. Hamm, Ph.D.Professor and Chair, Department of PharmacologyVanderbilt University School of Medicine

Edison T. Liu, M.D.President and Chief Executive OfficerThe Jackson Laboratory

Margaret A. Liu, M.D.Chair, Development Committee, Keystone SymposiaProTherImmune; Visiting Professor, Karolinska Institutet

Gary J. Nabel, M.D., Ph.D.Bethesda, Maryland

Tony Pawson, Ph.D.Senior InvestigatorCentre for Systems Biology, Samuel Lunenfeld Research Institute

Alan Sher, Ph.D.Chair, Nominating Committee, Keystone SymposiaBethesda, Maryland

Ian A. Wilson, Ph.D., Sc.D., FRSProfessor, Department of Molecular Biology and The Skaggs Institute for Chemical BiologyThe Scripps Research Institute

David L. Woodland, Ph.D.Chief Scientific OfficerKeystone Symposia on Molecular and Cellular Biology

EMERITUS BOARD MEMBERS

Ralph A. Bradshaw, Ph.D.Professor Emeritus, Physiology and BiophysicsCollege of Medicine, University of California, IrvineProfessor in Pharmaceutical Chemistry and Deputy Director of Mass Spectrometry Facility, University of California, San Francisco

Robert W. CraigPresident Emeritus, The Keystone Center

Edward A. Dennis, Ph.D.Professor, Chemistry, Biochemistry and PharmacologySchool of Medicine, University of California, San Diego

Curtis C. Harris, M.D.Chief, Laboratory of Human CarcinogenesisNCI/National Institutes of Health

James Aiken, Chief Executive OfficerPamela Daugherty, Chief Financial OfficerDavid Woodland, Chief Scientific OfficerJeannie Dalrymple, Senior Director, Program Development & ImplementationLinda Hrycaj, Senior Director, Strategic PlanningChristopher Atwood, Director, Development Heidi Daetwyler-Simpson, Director, Meeting ManagementLaina King, Director, Diversity in Life Science ProgramsTanya Muller, Director, Information TechnologyYvonne Psaila, Director, Marketing & CommunicationsMary Jo Roal, Director, Human Resources

David Adamson, On-Site RepresentativeCathy Banks, Web Developer/Systems AnalystKellan Barr, Marketing & Publications CoordinatorCarol Bosserman, On-Site RepresentativeMary Brown, On-Site RepresentativeCaroline Brendel, Executive Administrative AssistantMelissa Carrera, Assistant Director of DevelopmentLinda Cooper, Publications AssistantDoug Castle, Information Technology Programmer

Amanda Deem, Assistant Director of DevelopmentHeather Gerhart, Senior Grants Coordinator/Program AnalystSusan Gunn, Seasonal Logistics Assistant Lindsey Heilmann, Conference CoordinatorJenny Hindorff, Program Implementation AssociateSarah Lavicka, Administrative & Research Assistant, DevelopmentJeff Lehman, Scholarship CoordinatorPhyllis McNeil, Attendee Services RepresentativeAllison Ogdon, Program Development CoordinatorAnnie Page, On-Site RepresentativeMcKennzie Rains, IT Support/AssistantGrace Roath, Office ManagerJulie Roll, On-Site RepresentativeDavid Sanchez, Manager, Attendee Services Barbara Schmid-Miller, Program Implementation AssistantGwyn Schmude, Attendee Services RepresentativeDawn Shafer, Accounting ClerkBridget Stacy, Administrative Assistant, DiversityKathy Tavares, Program Development/Implementation SupervisorRebecca Wilkerson, Finance Assistant

14

Board of Directors (as of June 30, 2012)

Staff (as of June 30, 2012)

Margaret A. Liu, M.D.Chair, Development Committee, Keystone SymposiaProTherImmune; Visiting Professor, Karolinska Institutet

Gary J. Nabel, M.D., Ph.D.Bethesda, Maryland

Tony Pawson, Ph.D.Senior InvestigatorCentre for Systems Biology, Samuel Lunenfeld Research Institute

Alan Sher, Ph.D.Chair, Nominating Committee, Keystone SymposiaBethesda, Maryland

Ian A. Wilson, Ph.D., Sc.D., FRSProfessor, Department of Molecular Biology and The Skaggs Institute for Chemical BiologyThe Scripps Research Institute

David L. Woodland, Ph.D.Chief Scientific OfficerKeystone Symposia on Molecular and Cellular Biology

EMERITUS BOARD MEMBERS

Ralph A. Bradshaw, Ph.D.Professor Emeritus, Physiology and BiophysicsCollege of Medicine, University of California, IrvineProfessor in Pharmaceutical Chemistry and Deputy Director of Mass Spectrometry Facility, University of California, San Francisco

Robert W. CraigPresident Emeritus, The Keystone Center

Edward A. Dennis, Ph.D.Professor, Chemistry, Biochemistry and PharmacologySchool of Medicine, University of California, San Diego

Curtis C. Harris, M.D.Chief, Laboratory of Human CarcinogenesisNCI/National Institutes of Health

Amanda Deem, Assistant Director of DevelopmentHeather Gerhart, Senior Grants Coordinator/Program AnalystSusan Gunn, Seasonal Logistics Assistant Lindsey Heilmann, Conference CoordinatorJenny Hindorff, Program Implementation AssociateSarah Lavicka, Administrative & Research Assistant, DevelopmentJeff Lehman, Scholarship CoordinatorPhyllis McNeil, Attendee Services RepresentativeAllison Ogdon, Program Development CoordinatorAnnie Page, On-Site RepresentativeMcKennzie Rains, IT Support/AssistantGrace Roath, Office ManagerJulie Roll, On-Site RepresentativeDavid Sanchez, Manager, Attendee Services Barbara Schmid-Miller, Program Implementation AssistantGwyn Schmude, Attendee Services RepresentativeDawn Shafer, Accounting ClerkBridget Stacy, Administrative Assistant, DiversityKathy Tavares, Program Development/Implementation SupervisorRebecca Wilkerson, Finance Assistant

E. Dale Abel, M.D., Ph.D.Professor of Medicine, Biochemistryand Human GeneticsChief, Division of Endocrinology Metabolism and DiabetesThe University of Utah School of Medicine

Jacques F. Banchereau, Ph.D.

Stephen L. Brenner, Ph.D.Vice President of Molecular BiosciencesBristol-Myers Squibb Company

Leslie J. Browne, Ph.D.President and CEOSenesco Technologies, Inc.

Thomas F. Bumol, Ph.D.Vice President, BioTechnology ResearchLilly Research LaboratoriesPresident and Site Head, Applied Molecular Evolution, Inc. and Lilly Biotechnology Center – San Diego

Judith Campisi, Ph.D.ProfessorBuck Institute for Research on Aging

Arturo Casadevall, M.D.Professor and Chair, Microbiology and ImmunologyAlbert Einstein College of Medicine

Hubert C. Chen, M.D.Vice President, Translational MedicineRegulus Therapeutics Inc.

Robert L. Coffman, Ph.D.Vice President and Chief Scientific OfficerDynavax Technologies

Max D. Cooper, M.D.Georgia Research Alliance Eminent ScholarProfessor of Pathology and Laboratory MedicineEmory University School of Medicine

Rodrigo Corrêa-Oliveira, Ph.D. Senior Researcher Laboratório de Imunologia Celular e Molecular FIOCRUZ Minas

Alan J. Cross, Ph.D.Chief Scientist, CNS and Pain Innovative MedicinesAstraZeneca Pharmaceuticals

Manoj C. Desai, Ph.D.Vice President, Medicinal ChemistryGilead Sciences, Inc.

Vishva M. Dixit, M.D.Vice President, Research Physiological ChemistryGenentech, Inc.

Robert H. Eckel, M.D.Charles A. Boettcher Endowed Chair in AtherosclerosisProfessor of Medicine and of Physiology and BiophysicsProgram Director, Adult GCRCMedicine/EndocrinologyUniversity of Colorado Denver Anschutz Medical Campus

Martin P. Edwards, Ph.D.Vice President, Cancer ChemistryPfizer La Jolla

Lee M. Ellis, M.D.Professor, Cancer Biology and Surgical OncologyThe University of Texas MD Anderson Cancer Center

I. Sadaf Farooqi, Ph.D., FRCPWellcome Trust Senior Clinical Fellow and Reader in Human Metabolism, Metabolic Research LaboratoriesUniversity of Cambridge

Curt R. Freed, M.D.Professor and HeadDivision of Clinical Pharmacology and ToxicologyUniversity of Colorado Denver School of Medicine

Adolfo Garcia-Sastre, Ph.D.Professor, Department of Microbiology Co-Director, Emerging Pathogens InstituteMount Sinai School of Medicine

Tariq Ghayur, Ph.D.Research FellowAbbott Bioresearch Center

Douglas R. Green, Ph.D.Doherty Chair of ImmunologySt. Jude Children’s Research Hospital

Philip D. Gregory, Ph.D.Chief Scientific Officer, ResearchSangamo Biosciences, Inc.

Diane E. Griffin, M.D., Ph.D.Professor and ChairMolecular Microbiology and Immunology John Hopkins Bloomberg School of Public Health

Jacqueline E. Heard, Ph.D.Venture Capital PrincipalGlobal Strategy and R&D InvestmentMonsanto Company

Kim A. Heidenreich, Ph.D.Professor, Department of PharmacologyUniversity of Colorado Denver (UCHSC)

Linda Slanec Higgins, Ph.D. Vice President, Biology Gilead Sciences, Inc.

Christopher L. Karp, M.D.Professor, Director, Division of Molecular ImmunologyCincinnati Children’s Hospital Research Foundation

Elliott D. Kieff, M.D., Ph.D.Albee ProfessorMedicine, Microbiology and Molecular GeneticsHarvard University

Laura L. Kiessling, Ph.D.Hilldale Professor of ChemistryLaurens Anderson Professor of Biochemistry University of Wisconsin-Madison

Jacqueline Kirchner, Ph.D.Scientific Director, InflammationAmgen Inc.

Christopher Kirk, Ph.D.Director, Preclinical ResearchOnyx Pharmaceuticals, Inc.

Karla Kirkegaard, Ph.D. Professor, Microbiology and Immunology Stanford University School of Medicine

Jan E. Leach, Ph.D.University Distinguished ProfessorBioagricultural SciencesColorado State University

Karolin Luger, Ph.D.HHMI Investigator and ProfessorDepartment of Molecular Biology and BiochemistryColorado State University

Lamine Mbow, Ph.D. Director, Immunology and Inflammation Boehringer Ingelheim

Elizabeth M. McNally, M.D., Ph.D.Professor, Department of Medicine and Human GeneticsUniversity of Chicago

Juanita L. Merchant, M.D., Ph.D.Departments of Internal Medicine and Molecular and Integrative PhysiologyUniversity of Michigan

Tara Mirzadegan, Ph.D.Team Leader, Computational ChemistryJohnson & Johnson PharmaceuticalResearch & Development, L.L.C.

Peter Mueller, Ph.D. Executive Vice President, Global Research and Development and Chief Scientific Officer Vertex Pharmaceuticals Incorporated

Dominik Mumberg, Ph.D. Director, Cell Cycle and Survival Signaling Research Global Drug Discovery Bayer HealthCare

Donald W. Nicholson, Ph.D.Vice President, Worldwide Discovery Head, R&IMerck & Co., Inc.

Hiroyuki Odaka, Ph.D.General Manager, Pharmaceutical Research DivisionTakeda Pharmaceutical Company Limited

Anne O’Garra, Ph.D., FRS, FMedSciHead, Division of ImmunoregulationMRC National Institute for Medical Research

Vito J. Palombella, Ph.D. Chief Scientific Officer Infinity Pharmaceuticals, Inc.

Eric M. Parker, Ph.D.Senior Director and Neuroscience Site LeadNeurologyMerck Research Laboratories, Merck & Co., Inc.

Catherine E. Peishoff, Ph.D.Vice President, Computational and Structural ChemistryGlaxoSmithKline Pharmaceuticals

Ronald T. Raines, Ph.D.Professor, Departments of Biochemistry and ChemistryUniversity of Wisconsin–Madison

Roger R. Reddel, Ph.D.DirectorChildren’s Medical Research Institute, Sydney

Juan Rivera, Ph.D.Deputy Director, Intraumural Research ProgramChief, Laboratory of Molecular Immunogeneticsand Molecular Immunology SectionNIAMS, National Institutes of Health

Cristina M. Rondinone, Ph.D. Vice President, Research and Development Head, Cardiovascular and Metabolic Diseases MedImmune

Nadia A. Rosenthal, Ph.D.Director of EMBL Monterotondo, Mouse Biology UnitEuropean Molecular Biology Laboratory

Andrej Sali, Ph.D.Professor, Bioengineering and Therapeutic SciencesUniversity of California, San Francisco

Stephen J. Simpson, Ph.D.Life Sciences DirectorateScience Foundation Ireland

Frank J. Slack, Ph.D.ProfessorMolecular Cellular and Developmental BiologyYale University

Didier Y.R. Stainier, Ph.D.ProfessorDepartment of Biochemistry and BiophysicsSchool of MedicineUniversity of California, San Francisco

Eric E. Swayze, Ph.D.Vice President, Medicinal ChemistryIsis Pharmaceuticals, Inc.

Doris A. Taylor, Ph.D.Medtronic Bakken Chair of Physiology and MedicineDirector, Center for Cardiovascular RepairDepartment of Integrative Biology and Physiology University of Minnesota

Thomas Tuschl, Ph.D.HHMI Investigator and Associate ProfessorLaboratory of RNA Molecular BiologyThe Rockefeller Institute

Nicolai R. Wagtmann, Ph.D.Vice President and Head of Inflammation BiologyBiopharmaceuticals Research UnitNovo Nordisk A/S

Michael J.O. Wakelam, Ph.D.Institute DirectorThe Babraham Institute

Andrew Ward, Ph.D. Assistant Professor, Molecular Biology The Scripps Research Institute

David R. Webb, Ph.D.Adjunct Professor, Department of Molecular BiologyThe Scripps Research Institute

Kenneth F. Wertman, Ph.D.Scientific Director, TucsonAssociate Vice President, Discovery ResearchChemical and Analytical SciencesSanofi US

Scientific Advisory Board (as of June 30, 2012)

PO Box 1630 | 160 US Highway 6, Suite 200Silverthorne, Colorado 80498 | USA

1.970.262.1230 | 1.800.253.0685 www.keystonesymposia.org